Aspirin linked to lower colorectal cancer risk, especially for those who are less healthy

Publicly released:
International
Photo by Bermix Studio on Unsplash
Photo by Bermix Studio on Unsplash

The link between aspirin use and a lower colorectal cancer risk is strongest among those with less healthy lifestyles, according to international research. The researchers say previous studies have shown aspirin can reduce the risk of colorectal cancer, so they investigated who might see the greatest risk reduction if they took the painkiller. Using data from a long-term women's health study, the team compared aspirin usage, various measures to calculate how healthy a participant's lifestyle is and the rate of colorectal cancer among over 100,000 women. The researchers say the colorectal cancer rate over the study was 1.98% for those who used aspirin regularly and 2.95% for those who didn't. Participants with less healthy lifestyles saw a greater overall risk reduction from aspirin usage compared to healthier participants, the researchers say, which could help identify the kind of people more likely to see more of a benefit than a risk from regularly taking aspirin.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Oncology
Research:Paper
Organisation/s: Harvard Medical School, USA
Funder: This work was supported by infrastructure grants UM1 CA186107 and P01 CA87969 for the Nurses’ Health study; infrastructure grant U01 CA167552 for the Health Professionals Follow-Up Study; K99CA283146 (DrWang); American Gastroenterological Association AGA2021-13-01 and MGH Claflin Distinguished Scholar Award (Dr Ma); K01DK120742 (Dr Drew); R35 CA197735 (Dr Ogino); American Cancer Society CRP-23-1014041 (Dr Giovannucci); K07CA218377 and R37CA246175 (Dr Cao); K23DK125838, American Gastroenterological Association Research Scholars Award, Crohn’s and Colitis Foundation Career Development Award, MGH/Tianqiao & Chrissy Chen Institute Transformative Scholars Award (Dr Nguyen); and R35 CA253185 and American Cancer Society Research Professor (Dr Chan).
Media Contact/s
Contact details are only visible to registered journalists.